Efficacy and Safety of 500mg of Fulvestrant
Clinical trial NCT00585507 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT00585507
- Sponsor
- Beth Israel Deaconess Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Primary completion
- 2027-03-15
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.